Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)

NCT05294744 is registered in ClinicalTrials.gov with Bioaraba Health Research Institute as lead sponsor.

NCT NCT05294744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05294744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)
Lead sponsor
Bioaraba Health Research Institute
Phase
Not applicable
Overall status
Recruiting
Start date
October 7, 2022
Completion date
December 31, 2026
Enrollment
390 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic hepatitis